Events and Presentations

Upcoming Events and Presentations

Kiniksa Presents Preclinical Data Supporting KPL-716 Clinical Development at the 49th Annual Meeting of the European Society of Dermatological Research

September 19, 2019

Supporting Materials

View Presentation 996.2 KB

Past Events

Investor Presentation

September 12, 2019

Supporting Materials

View Presentation 4.1 MB

Kiniksa Presents a Retrospective Claims Analysis of Recurrent Pericarditis Epidemiology in the U.S. at the American College of Epidemiology

September 09, 2019 at 5:30 PM EDT

Supporting Materials

View Presentation 376.2 KB

Kiniksa Presents Rilonacept Phase 3 Methods (RHAPSODY) at ESC 2019

September 02, 2019

Supporting Materials

View Presentation 722.7 KB

2019 Wedbush PacGrow Healthcare Conference

August 13, 2019 at 12:45 PM EDT

Listen to Webcast

Kiniksa Announces Interim Data from KPL-716 Repeated-Single-Dose Phase 1b Clinical Trial

August 12, 2019

Supporting Materials

View Presentation 987.5 KB

JMP Securities 2019 Life Sciences Conference

June 19, 2019 at 10:00 AM EDT

Listen to Webcast

Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at EULAR 2019

June 13, 2019

Supporting Materials

View Abstract 236.9 KB

View Poster: GM-CSF Pathway Signature Identified in Temporal Artery Biopsies of Patients With Giant Cell Arteritis 1.5 MB

Goldman Sachs 40th Annual Global Healthcare Conference

June 11, 2019 at 2:00 PM PDT

Listen to Webcast

Jefferies 2019 Global Healthcare Conference

June 05, 2019 at 10:00 AM EDT

Listen to Webcast

Kiniksa Presents Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research

May 21, 2019

Supporting Materials

Unmet Needs & Burden Of Recurrent Pericarditis (RP): Results Of A Systematic Literature Review (SLR) 966.3 KB

Kiniksa Presents Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology

May 10, 2019

Supporting Materials

View Poster: KPL-716, Anti-OSMRβ Antibody, Reduced Pruritus in Atopic Dermatitis 920.5 KB

View Poster: The OSMRβ Axis Identified in Prurigo Nodularis 963.8 KB

View Poster: OSM Induction of Monocyte Chemoattractant Protein 1 (MCP-1) in Human Epidermal Keratinocytes is Inhibited by Anti-OSMRβ Monoclonal Antibody KPL-716 402.9 KB

View Poster: KPL-716, an OSMRβ Monoclonal Antibody, Reduces IL-31-Induced Scratching Behavior in Cynomolgus Monkeys: Establishment and Optimization of Pharmacokinetic/Pharmacodynamic Model 698.6 KB

Kiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology

April 19, 2019

Supporting Materials

View Abstract: KPL-716, Anti-OSMRβ Antibody, Reduced Pruritus in Atopic Dermatitis 110.9 KB

View Abstract: OSM Induction of Monocyte Chemoattractant Protein 1 (MCP-1) in Human Epidermal Keratinocytes is Inhibited by Anti-OSMRβ Monoclonal Antibody KPL-716 63.8 KB

View Abstract: The OSMRβ Axis Identified in Prurigo Nodularis 128.1 KB

View Abstract: KPL-716, an OSMRβ Monoclonal Antibody, Reduces IL-31-Induced Scratching Behavior in Cynomolgus Monkeys: Establishment and Optimization of Pharmacokinetic/Pharmacodynamic Model 96.4 KB

Kiniksa Presents KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs

April 10, 2019

Supporting Materials

View Poster 1.1 MB

Kiniksa Presents Poster with Design of Global Phase 2 Clinical Trial of Mavrilimumab in Giant Cell Arteritis at the 19th International Vaculitis and ANCA Workshop

April 10, 2019

Supporting Materials

View Poster 802.5 KB

Kiniksa Presents Encore Poster of KPL-716 Phase 1a/1b Clinical Data at Revolutionizing Atopic Dermatitis (RAD)

April 08, 2019

Supporting Materials

View Poster 848.7 KB

Kiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiology’s 68th Annual Scientific Session

March 17, 2019

Supporting Materials

View Poster and Supplement 6.5 MB

View Presentation 1.4 MB

Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial

December 11, 2018 at 9:00 AM EST

Supporting Materials

View Presentation 526.7 KB

Investors & Media